Other Precautions: The elimination half-life of Irsogladine maleate from plasma in healthy male adults is about 150 hours. The drug should be used with precaution in patients with renal and liver diseases.
Effects on ability to drive and use machine: Effects on ability to drive and use machines have not been studied.
Use in Children: Safety in pediatric patients has not been established (insufficient clinical experience).
Use in the Elderly: Since the elderly patients often have a physiological hypofunction, this drug should be carefully administered such as starting at a low dose (e.g. 2 mg/day) while closely monitoring the patient's condition.
Sign Out